Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Genetics Institute's BeneFix

Executive Summary

Genetics Institute's BeneFix: Recombinant factor IX product review status will be discussed at FDA Blood Products Advisory Committee meeting on Dec. 12 at 8 a.m. at Bethesda, Md. Holiday Inn. FDA proposal on limiting plasma pool size for fractionated plasma products also will be reviewed. In addition, the committee will consider safety and efficacy of solvent detergent plasma from the New York Blood Center...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029210

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel